DFDA

Liver Transplantation

Treatment for Liver Cancer Due To Hepatitis C

Effectiveness
95%
Safety Score
40%
Clinical Trials
500
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Time to Effect
Months to years for sustained benefit
Treatment Duration
Lifetime (immunosuppression)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$10,000
Side Effect Mgmt:$7,500
Total Annual:$32,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$150,000/QALY
QALYs Gained
8
Liver Transplantation Outcomes

for Liver Cancer Due To Hepatitis C

Efficacy Outcomes
Overall Effectiveness
+95%
Remission Rate
+75%
Common Side Effects
Rejection
+20%
Infection
+60%
Kidney dysfunction
+30%
Cancer recurrence
+15%

Sources:

frontiersin.org
nih.gov
amegroups.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov